Safety and Efficacy of Adalimumab (Humira) for Hidradenitis Suppurativa (HS) Peri-Surgically
Status:
Completed
Trial end date:
2019-10-16
Target enrollment:
Participant gender:
Summary
The objective of this study was to assess the safety and efficacy of adalimumab prior to
surgery in participants with moderate to severe Hidradenitis Suppurativa (HS) who were
surgical candidates.